Cover Image
Market Research Report

Biopharmaceutical Market: By Source By Products Manufacturing Process Application End Users -Forecast 2019-2024

Published by IndustryARC Product code 409043
Published Content info
Delivery time: 2-3 business days
Price
Back to Top
Biopharmaceutical Market: By Source By Products Manufacturing Process Application End Users -Forecast 2019-2024
Published: December 19, 2018 Content info:
Description

Biopharmaceuticals are large and complex products isolated from genetically modified living organisms. Recently, biologics or biopharmaceuticals is one of the fastest growing sectors of pharmaceutical industries, owing to its innovative nature, greater safety and efficacy compared to traditional drugs.

The market for Biopharmaceutical is classified into three categories based on source, type of products and application areas, each of these segments are further broken down into sub-segments to give a comprehensive analysis of global biopharmaceuticals market.

The overall Biopharmaceutical Market has also been presented from the perspective of different geographic locations and key economies in this market. Competitors are highlighted and market players are profiled with attributes covering company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of each of the prominent players for 2015 are detailed.

The market is largely dominated by North America which accounted for about half of the global share. APAC is a promising market and is opening gateways for new manufacturers.

The report also provides a detailed qualitative analysis of the factors responsible for driving and hindering the growth of the Biopharmaceuticals market and future opportunities that can propel the market.

The report contains the most detailed and in-depth segmentation and analysis of the Global Biopharmaceuticals Market during the forecast period 2015 - 2020.

Sample Companies Profiled in this Report are:

BioMarin Pharmaceutical Inc.

AbbVie Inc.

Invion Limited

AdAlta Pty Ltd.

Admedus Ltd

30+.

Table of Contents

Table of Contents

1. Global Biopharmaceutical Market Overview

2. Executive Summary

3. Global Biopharmaceutical Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. Patent Analysis
    • 3.2.3. End user profiling
    • 3.2.4. Top 5 Financials Analysis

4. Global Biopharmaceutical Market Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints
  • 4.3. Market Challenges
  • 4.4. Attractiveness of the Industry
    • 4.4.1. Power of Suppliers
    • 4.4.2. Power of Customers
    • 4.4.3. Threat of New entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. Global Biopharmaceutical Market Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Opportunities Analysis
  • 5.3. Product lifecycle
  • 5.4. Pricing Analysis

6. Global Biopharmaceutical Market- By Source

  • 6.1. Unicellular System
    • 6.1.1. Bacteria
    • 6.1.2. Yeast
    • 6.1.3. Insect
  • 6.2. Multicellular System
    • 6.2.1. Transgenic Plant
    • 6.2.2. Transgenic Animal

7. Global Biopharmaceutical Market- By Products

  • 7.1. Vaccines
  • 7.2. Hormones
  • 7.3. Enzymes
  • 7.4. Blood
  • 7.5. Blood Components
  • 7.6. Monoclonal Antibodies
  • 7.7. Growth Factors
  • 7.8. Gene Therapies
  • 7.9. Thrombolytics and Anticoagulants
  • 7.10. Recombinant Therapeutic Protein

8. Global Biopharmaceutical Market- By Manufacturing Process

  • 8.1. Single-Use System
  • 8.2. Multi- Use System

9. Global Biopharmaceutical Market- By Application

  • 9.1. Rheumatology
  • 9.2. Oncology
  • 9.3. Cardiology
  • 9.4. Dermatology
  • 9.5. Gastroenterology
  • 9.6. Neurology
  • 9.7. Others

10. Global Biopharmaceutical Market- By End Users

  • 10.1. Biopharmaceutical Companies
  • 10.2. Hospitals
  • 10.3. Research Institutes
  • 10.4. CROs
  • 10.5. Diagnostic Labs

11. Global Biopharmaceutical Market -Geographic Analysis

  • 11.1. North America
    • 11.1.1. Canada
    • 11.1.2. Mexico
    • 11.1.3. USA
    • 11.1.4. Others
  • 11.2. Europe
    • 11.2.1. France
    • 11.2.2. Germany
    • 11.2.3. Italy
    • 11.2.4. Sweden
    • 11.2.5. U.K
    • 11.2.6. Others
  • 11.3. APAC
    • 11.3.1. China
    • 11.3.2. India
    • 11.3.3. Japan
    • 11.3.4. Australia
    • 11.3.5. Others
  • 11.4. ROW
    • 11.4.1. South Africa
    • 11.4.2. South America
    • 11.4.3. Russia
    • 11.4.4. Saudi Arabia
    • 11.4.5. Others

12. Market Entropy

  • 12.1. New Product Launches
  • 12.2. M&As, Collaborations, JVs and Partnerships

13. Company profiles

  • 13.1. Johnson & Johnson Private Limited
  • 13.2. Roche Holding AG
  • 13.3. Abbott Laboratories
  • 13.4. Bristol-Myers Squibb
  • 13.5. Novartis International AG
  • 13.6. Genentech Inc.
  • 13.7. UCB
  • 13.8. Merck Serono
  • 13.9. Amgen
  • 13.10. Eli Lilly & Co.
  • 13.11. Biogen Idec
  • 13.12. Merck KGaA
  • 13.13. Elan Corporation
  • 13.14. BioMarin Pharmaceutical Inc.
  • 13.15. AbbVie Inc.
  • 13.16. Invion Limited
  • 13.17. AdAlta Pty Ltd.
  • 13.18. Admedus Ltd
  • 13.19. Biota Pharmaceuticals Inc.
  • 13.20. Novozymes
  • 13.21. Baxter International
  • 13.22. APEIRON Biologics AG
  • 13.23. Octapharma AG
  • 13.24. Valneva SE
  • 13.25. Genzyme
  • 13.26. Mallinckrodt Pharmaceuticals
  • 13.27. TM3 Therapeutics

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

14. Appendix

  • 14.1. Abbreviations
  • 14.2. Sources
  • 14.3. Research Methodology
  • 14.4. Bibliography
  • 14.5. Compilation of Expert Insights
  • 14.6. Disclaimer
Back to Top